AKT1 and neoplasm: PTEN’s tumor-suppressive function is thought to be secondary to dephosphorylation and inactivation of the lipid second messenger phosphatidylinositol-3,4,5-triphosphosphate, a potent PI3K/AKT/mTOR pathway activator11–13.